login
who are we?
contact us
qosheapp
Toi Staff
Belen Fernandez
Tafi Mhaka
Tarik Cyril Amar
Gideon Levy
Dr Ramzy Baroud
Rachel Marsden
Ghada Ageel
Sabine Sterk
Somdeep Sen
Muhannad Ayyash
Stephanie A. Sarkis Ph.d
John Nosta
Sabine Kinkartz
Federal judge extends block on public health cuts
Health Care
Health Care
The Big Story
Federal judge extends block on public health cuts
A federal judge indefinitely blocked the Department of Health and Human Services (HHS) from canceling $11 billion in public health grants set for state and local health departments.
© The Hill, Greg Nash
Judge Mary McElroy of the U.S. District Court for the District of Rhode Island ruled Friday to extend a temporary restraining order she issued last month that barred the Trump administration from wiping out pandemic-era funding to Washington D.C., and 23 Democratic-led states.
States behind the lawsuit argued that HHS acted unlawfully by abruptly ending the grant funding without any analysis of the move’s benefits or consequences.
HHS said that the $11.4 billion worth of grant funding was mainly used to pay for testing, vaccines and hiring community health workers to combat COVID-19. And the agency argues since the pandemic is over, state and local health agencies no longer need that money.
Although the grants were initially authorized by COVID-19 relief legislation, the funds were allowed to be spent on other efforts like combating the ongoing measles outbreak in Texas. State and local health departments said the funds were already being used for such efforts.
McElroy ruled that the agency does not have the legal right to unilaterally withhold the grant funding that has already been allocated to localities, especially in states where that funding has been used to build essential health programs.
She wrote in her ruling that the funding cuts would “result in devastating consequences to their local jurisdictions ... would constrain the States’ infectious disease research, thwart treatment efforts to those struggling with mental health and addiction, and impact the availability of vaccines to children, the elderly and those living in rural areas.”
Welcome to The Hill’s Health Care newsletter, we’re Nathaniel Weixel, Joseph Choi and Alejandra O'Connell-Domenech — every week we follow the latest moves on how Washington impacts your health.
Did someone forward you this newsletter? Subscribe here.
Essential Reads
How policy will be impacting the health care sector this week and beyond:
FDA clears first blood test to reliably predict Alzheimer’s disease
The Food and Drug Administration (FDA) announced Friday it had cleared a new test to help diagnose adults with Alzheimer’s disease, the first diagnostic tool that uses a blood draw to check for the illness. The test is called the “Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio” and is developed by the Japanese company Fujirebio Diagnostics Inc. It measures specific biomarkers and proteins associated with …
© The Hill
visit website